Altfest L J & CO Inc Bristol Myers Squibb CO Transaction History

Altfest L J & CO Inc

$751 Million
Q3 2024

A detailed history of Altfest L J & CO Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Altfest L J & CO Inc holds 26,946 shares of BMY stock, worth $1.56 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

26,946

Previous 26,366 2.2%

Holding current value

$1.56 Million

Previous $1.1 Million 27.31%

% of portfolio

0.19%

Previous 0.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$39.66 - $51.75 $23,002 - $30,015	580 Added 2.2%	26,946 $1.39 Million
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $3,340 - $4,398	-83 Reduced 0.31%	26,366 $1.1 Million
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $11,131 - $12,620	-232 Reduced 0.87%	26,449 $1.43 Million
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $168,128 - $200,623	-3,468 Reduced 11.5%	26,681 $1.37 Million
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $156,997 - $175,547	-2,712 Reduced 8.25%	30,149 $1.75 Million
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $153,286 - $170,200	2,406 Added 7.9%	32,861 $2.1 Million
Q1 2023 Apr 20, 2023	SELL	$65.71 - $74.53 $10,776 - $12,222	-164 Reduced 0.54%	30,455 $2.11 Million
Q4 2022 Feb 02, 2023	SELL	$68.48 - $81.09 $48,141 - $57,006	-703 Reduced 2.24%	30,619 $2.2 Million
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $5 - $3,534	-46 Reduced 0.15%	31,322 $2.23 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $19,607 - $21,594	-270 Reduced 0.85%	31,368 $2.42 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $486,983 - $583,936	-7,921 Reduced 20.02%	31,638 $2.31 Million
Q4 2021 Jan 24, 2022	BUY	$53.63 - $62.52 $478,433 - $557,740	8,921 Added 29.12%	39,559 $2.47 Million
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $196,976 - $230,732	-3,329 Reduced 9.8%	30,638 $1.81 Million
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $23,587 - $25,687	-381 Reduced 1.11%	33,967 $2.27 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $17,920 - $20,155	302 Added 0.89%	34,348 $2.17 Million
Q4 2020 Jan 21, 2021	BUY	$57.74 - $65.43 $193,140 - $218,863	3,345 Added 10.9%	34,046 $2.11 Million
Q3 2020 Oct 29, 2020	SELL	$57.43 - $63.64 $79,425 - $88,014	-1,383 Reduced 4.31%	30,701 $1.85 Million
Q2 2020 Jul 21, 2020	SELL	$54.82 - $64.09 $258,914 - $302,697	-4,723 Reduced 12.83%	32,084 $1.89 Million
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $14,616 - $21,240	-315 Reduced 0.85%	36,807 $2.05 Million
Q4 2019 Jan 06, 2020	BUY	$49.21 - $64.19 $7,529 - $9,821	153 Added 0.41%	37,122 $2.38 Million
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $243,061 - $288,184	-5,683 Reduced 13.32%	36,969 $1.88 Million
Q2 2019 Jul 15, 2019	SELL	$44.62 - $49.34 $59,924 - $66,263	-1,343 Reduced 3.05%	42,652 $1.93 Million
Q1 2019 Jun 10, 2019	SELL	$45.12 - $53.8 $55,497 - $66,174	-1,230 Reduced 2.72%	43,995 $2.1 Million
Q1 2019 May 24, 2019	BUY	$45.12 - $53.8 $1.2 Million - $1.43 Million	26,604 Added 142.87%	45,225 $2.35 Million
Q1 2019 Apr 05, 2019	SELL	$45.12 - $53.8 $1.2 Million - $1.43 Million	-26,604 Reduced 58.83%	18,621 $2.4 Million
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $125,020 - $162,121	-2,564 Reduced 5.37%	45,225 $2.35 Million
Q3 2018 Oct 10, 2018	SELL	$55.19 - $62.25 $8,885 - $10,022	-161 Reduced 0.34%	47,789 $2.97 Million
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $592,413 - $738,377	-11,724 Reduced 19.65%	47,950 $2.65 Million
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $67,469 - $77,671	-1,126 Reduced 1.85%	59,674 $3.77 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $194,025 - $211,537	3,237 Added 5.62%	60,800 $3.73 Million
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $3.18 Million - $3.67 Million	57,563	57,563 $3.67 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.

Account